Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03374631 · ClinicalTrials.gov registry record · NA
Stimulating the Social Brain
A NA study of Healthy Adults, sponsored by The University of Texas at Dallas.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03374631: Completed NA study of Healthy Adults, sponsored by The University of Texas at Dallas.
NCT03374631 is a NA study of Healthy Adults that has completed, run by The University of Texas at Dallas. The registered enrollment target is 40 participants, below the 85-participant average among 33 other Healthy Adults trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03374631, a NA study of Healthy Adults, has completed, sponsored by The University of Texas at Dallas.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates whether the way in which individuals process social stimuli can be altered, and specifically, whether feelings of paranoia and suspiciousness can be reduced by stimulating the brain's regulatory regions via transcranial Direct Current Stimulation (tDCS).
Primary Outcome
Level of paranoid ideation will be assessed with the self-report Paranoia Scale (PS; Fenigstein \& Vanable, 1992) both before and after tDCS to assess changes related to tDCS. The PS is a self-report measure designed to assess sub-clinical paranoid thought. Scores range from 20-100 with higher scores indicating higher levels of paranoia. The amount of pre-post change (i.e. PS score assessed before stimulation minus score after stimulation) is the primary value of interest and will be compared be
Conditions Studied
Interventions
- DEVICE sham tDCS
- DEVICE active anodal tDCS
Study Locations (1)
Texas
- The Unversity of Texas at Dallas - Richardson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2020-10-01 |
| Phase | NA |
What the finished NCT03374631 record still lists
NCT03374631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 85-participant average among 33 other Healthy Adults trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Healthy Adults appearing as the primary indexed condition, and to 2 interventions - of which sham tDCS is the first listed.
NCT03374631 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03374631 about?
NCT03374631 is a clinical study titled "Stimulating the Social Brain". This study investigates whether the way in which individuals process social stimuli can be altered, and specifically, whether feelings of paranoia and suspiciousness can be reduced by stimulating the brain's regulatory regions via transcranial Direct Current Stimulation (tDCS).
What is the current status of trial NCT03374631?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2017-12-01. Estimated completion is 2020-10-01.
What conditions does trial NCT03374631 study?
This clinical trial studies the following conditions: Healthy Adults.
What interventions are being tested in trial NCT03374631?
The interventions under investigation include: sham tDCS (DEVICE), active anodal tDCS (DEVICE).
Who is sponsoring clinical trial NCT03374631?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03374631 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adults
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03374631's enrollment target sits among peer trials
40 12th of 33 higher than 19 of 33 other Healthy Adults trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Adults trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
RECRUITING · NA
-
Health Properties of Pecan Nut Consumption
RECRUITING · NA
-
The Brain Processes Underlying Speech Motor Learning and Speech Production
RECRUITING · NA
-
Effect of Acute Nitrate Supplementation on Vascular Function in Hispanic, Black and White Population
RECRUITING · NA
-
Pilot Study of the Entarik System With Advanced Functionality in Health Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI